$FATE Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in FATE THERAPEUTICS INC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of all insider trading transactions in FATE THERAPEUTICS INC. Get notifications about new insider transactions in FATE THERAPEUTICS INC for free.

Page:   1 2 3 4 4 next >

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 04 2021FATEFATE THERAPEUTICS ...Jooss KarinDirectorOption ExerciseA68.944,334298,7864,334
Jun 04 2021FATEFATE THERAPEUTICS ...Jooss KarinDirectorGrantA0.002,68102,6810 to 2.7 K
Jun 04 2021FATEFATE THERAPEUTICS ...RASTETTER WILLIAM HDirectorOption ExerciseA68.944,334298,7864,334
Jun 04 2021FATEFATE THERAPEUTICS ...RASTETTER WILLIAM HDirectorGrantA0.002,68102,6810 to 2.7 K
May 24 2021FATEFATE THERAPEUTICS ...Wolchko J ScottPresident and CEOOption ExerciseM4.8420,00096,70044,846
May 24 2021FATEFATE THERAPEUTICS ...Wolchko J ScottPresident and CEOSellS77.1620,0001,543,292393,793413.8 K to 393.8 K (-4.83 %)
May 24 2021FATEFATE THERAPEUTICS ...Wolchko J ScottPresident and CEOBuyM4.8420,00096,700413,793393.8 K to 413.8 K (+5.08 %)
Apr 26 2021FATEFATE THERAPEUTICS ...Wolchko J ScottPresident and CEOOption ExerciseM4.845,15424,92064,846
Apr 26 2021FATEFATE THERAPEUTICS ...Wolchko J ScottPresident and CEOOption ExerciseM6.6214,84698,2810
Apr 26 2021FATEFATE THERAPEUTICS ...Wolchko J ScottPresident and CEOOption ExerciseM2.7310,00027,300130,000
Apr 26 2021FATEFATE THERAPEUTICS ...Wolchko J ScottPresident and CEOOption ExerciseM2.7330,00081,900140,000
Apr 26 2021FATEFATE THERAPEUTICS ...Wolchko J ScottPresident and CEOSellS85.2430,0002,557,284393,793423.8 K to 393.8 K (-7.08 %)
Apr 26 2021FATEFATE THERAPEUTICS ...Wolchko J ScottPresident and CEOBuyM4.845,15424,920423,793418.6 K to 423.8 K (+1.23 %)
Apr 26 2021FATEFATE THERAPEUTICS ...Wolchko J ScottPresident and CEOBuyM6.6214,84698,281418,639403.8 K to 418.6 K (+3.68 %)
Apr 26 2021FATEFATE THERAPEUTICS ...Wolchko J ScottPresident and CEOBuyM2.7310,00027,300403,793393.8 K to 403.8 K (+2.54 %)
Apr 26 2021FATEFATE THERAPEUTICS ...Wolchko J ScottPresident and CEOSellS85.5430,0002,566,212393,793423.8 K to 393.8 K (-7.08 %)
Apr 26 2021FATEFATE THERAPEUTICS ...Wolchko J ScottPresident and CEOBuyM2.7330,00081,900423,793393.8 K to 423.8 K (+7.62 %)
Apr 20 2021FATEFATE THERAPEUTICS ...Chu Yu-WayeSenior VP Clinical ...SellS84.411,500126,61564,80066.3 K to 64.8 K (-2.26 %)
Apr 20 2021FATEFATE THERAPEUTICS ...Chu Yu-WayeSenior VP Clinical ...SellS82.9190074,61966,30067.2 K to 66.3 K (-1.34 %)
Apr 20 2021FATEFATE THERAPEUTICS ...Chu Yu-WayeSenior VP Clinical ...SellS81.8087571,57567,20068.1 K to 67.2 K (-1.29 %)
Apr 02 2021FATEFATE THERAPEUTICS ...TAHL CINDYSee RemarksOption ExerciseM7.871,85114,56710,458
Apr 02 2021FATEFATE THERAPEUTICS ...TAHL CINDYSee RemarksOption ExerciseM2.9028,14981,6320
Apr 02 2021FATEFATE THERAPEUTICS ...TAHL CINDYSee RemarksSellS87.4540034,979108,048108.4 K to 108 K (-0.37 %)
Apr 02 2021FATEFATE THERAPEUTICS ...TAHL CINDYSee RemarksSellS86.765,299459,733108,448113.7 K to 108.4 K (-4.66 %)
Apr 02 2021FATEFATE THERAPEUTICS ...TAHL CINDYSee RemarksSellS85.984,835415,733113,747118.6 K to 113.7 K (-4.08 %)
Apr 02 2021FATEFATE THERAPEUTICS ...TAHL CINDYSee RemarksSellS84.482,200185,865118,582120.8 K to 118.6 K (-1.82 %)
Apr 02 2021FATEFATE THERAPEUTICS ...TAHL CINDYSee RemarksSellS83.403,490291,080120,782124.3 K to 120.8 K (-2.81 %)
Apr 02 2021FATEFATE THERAPEUTICS ...TAHL CINDYSee RemarksSellS82.694,556376,714124,272128.8 K to 124.3 K (-3.54 %)
Apr 02 2021FATEFATE THERAPEUTICS ...TAHL CINDYSee RemarksSellS81.488,220669,731128,828137 K to 128.8 K (-6.00 %)
Apr 02 2021FATEFATE THERAPEUTICS ...TAHL CINDYSee RemarksSellS80.491,00080,494137,048138 K to 137 K (-0.72 %)
Apr 02 2021FATEFATE THERAPEUTICS ...TAHL CINDYSee RemarksBuyM7.871,85114,567138,048136.2 K to 138 K (+1.36 %)
Apr 02 2021FATEFATE THERAPEUTICS ...TAHL CINDYSee RemarksBuyM2.9028,14981,632136,197108 K to 136.2 K (+26.05 %)
Mar 09 2021FATEFATE THERAPEUTICS ...Shoemaker Daniel DChief Scientific Of ...SellS86.7080069,36073,02073.8 K to 73 K (-1.08 %)
Mar 09 2021FATEFATE THERAPEUTICS ...Shoemaker Daniel DChief Scientific Of ...SellS85.502,900247,95673,82076.7 K to 73.8 K (-3.78 %)
Mar 09 2021FATEFATE THERAPEUTICS ...Shoemaker Daniel DChief Scientific Of ...SellS84.202,728229,70576,72079.4 K to 76.7 K (-3.43 %)
Mar 09 2021FATEFATE THERAPEUTICS ...Shoemaker Daniel DChief Scientific Of ...SellS83.462,480206,98979,44881.9 K to 79.4 K (-3.03 %)
Mar 09 2021FATEFATE THERAPEUTICS ...Shoemaker Daniel DChief Scientific Of ...SellS81.602,993244,22481,92884.9 K to 81.9 K (-3.52 %)
Mar 09 2021FATEFATE THERAPEUTICS ...Shoemaker Daniel DChief Scientific Of ...SellS80.735,174417,72284,92190.1 K to 84.9 K (-5.74 %)
Mar 09 2021FATEFATE THERAPEUTICS ...Shoemaker Daniel DChief Scientific Of ...SellS79.584,627368,23690,09594.7 K to 90.1 K (-4.88 %)
Mar 09 2021FATEFATE THERAPEUTICS ...Shoemaker Daniel DChief Scientific Of ...SellS78.603,298259,23694,72298 K to 94.7 K (-3.36 %)
Feb 19 2021FATEFATE THERAPEUTICS ...Wolchko J ScottPresident and CEOOption ExerciseM6.6220,000132,40014,846
Feb 19 2021FATEFATE THERAPEUTICS ...Wolchko J ScottPresident and CEOSellS103.165,547572,206393,793399.3 K to 393.8 K (-1.39 %)
Feb 19 2021FATEFATE THERAPEUTICS ...Wolchko J ScottPresident and CEOSellS102.268,602879,661399,340407.9 K to 399.3 K (-2.11 %)
Feb 19 2021FATEFATE THERAPEUTICS ...Wolchko J ScottPresident and CEOSellS101.422,602263,883407,942410.5 K to 407.9 K (-0.63 %)
Feb 19 2021FATEFATE THERAPEUTICS ...Wolchko J ScottPresident and CEOSellS100.481,848185,691410,544412.4 K to 410.5 K (-0.45 %)
Feb 19 2021FATEFATE THERAPEUTICS ...Wolchko J ScottPresident and CEOSellS99.081,401138,817412,392413.8 K to 412.4 K (-0.34 %)
Feb 19 2021FATEFATE THERAPEUTICS ...Wolchko J ScottPresident and CEOBuyM6.6220,000132,400413,793393.8 K to 413.8 K (+5.08 %)
Jan 21 2021FATEFATE THERAPEUTICS ...TAHL CINDYGeneral Counsel and ...Option ExerciseM2.9035,000101,50028,149
Jan 21 2021FATEFATE THERAPEUTICS ...TAHL CINDYGeneral Counsel and ...SellS117.0720023,41390,03590.2 K to 90 K (-0.22 %)
Jan 21 2021FATEFATE THERAPEUTICS ...TAHL CINDYGeneral Counsel and ...SellS115.974,021466,33390,23594.3 K to 90.2 K (-4.27 %)
Jan 21 2021FATEFATE THERAPEUTICS ...TAHL CINDYGeneral Counsel and ...SellS115.0914,9441,719,93594,256109.2 K to 94.3 K (-13.68 %)
Jan 21 2021FATEFATE THERAPEUTICS ...TAHL CINDYGeneral Counsel and ...SellS114.1115,8351,806,959109,200125 K to 109.2 K (-12.66 %)
Jan 21 2021FATEFATE THERAPEUTICS ...TAHL CINDYGeneral Counsel and ...BuyM2.9035,000101,500125,03590 K to 125 K (+38.87 %)
Jan 12 2021FATEFATE THERAPEUTICS ...Wolchko J ScottPresident and CEOSellS109.652,300252,204350,562352.9 K to 350.6 K (-0.65 %)
Jan 12 2021FATEFATE THERAPEUTICS ...Wolchko J ScottPresident and CEOSellS110.762,772307,021352,862355.6 K to 352.9 K (-0.78 %)
Jan 12 2021FATEFATE THERAPEUTICS ...Wolchko J ScottPresident and CEOSellS111.623,515392,330355,634359.1 K to 355.6 K (-0.98 %)
Jan 12 2021FATEFATE THERAPEUTICS ...Wolchko J ScottPresident and CEOSellS114.761,469168,575359,149360.6 K to 359.1 K (-0.41 %)
Jan 12 2021FATEFATE THERAPEUTICS ...Wolchko J ScottPresident and CEOSellS115.808,515986,028360,618369.1 K to 360.6 K (-2.31 %)
Jan 12 2021FATEFATE THERAPEUTICS ...Wolchko J ScottPresident and CEOSellS117.1523,9322,803,730369,133393.1 K to 369.1 K (-6.09 %)
Jan 12 2021FATEFATE THERAPEUTICS ...Wolchko J ScottPresident and CEOSellS117.6026,9043,163,883393,065420 K to 393.1 K (-6.41 %)
Jan 12 2021FATEFATE THERAPEUTICS ...Valamehr BahramChief Development O ...SellS109.6587195,50977,72778.6 K to 77.7 K (-1.11 %)
Jan 12 2021FATEFATE THERAPEUTICS ...Valamehr BahramChief Development O ...SellS110.761,051116,40778,59879.6 K to 78.6 K (-1.32 %)
Jan 12 2021FATEFATE THERAPEUTICS ...Valamehr BahramChief Development O ...SellS111.621,332148,67379,64981 K to 79.6 K (-1.64 %)
Jan 12 2021FATEFATE THERAPEUTICS ...Valamehr BahramChief Development O ...SellS114.7615117,32880,98181.1 K to 81 K (-0.19 %)
Jan 12 2021FATEFATE THERAPEUTICS ...Valamehr BahramChief Development O ...SellS115.80872100,97781,13282 K to 81.1 K (-1.06 %)
Jan 12 2021FATEFATE THERAPEUTICS ...Valamehr BahramChief Development O ...SellS117.152,451287,14482,00484.5 K to 82 K (-2.90 %)
Jan 12 2021FATEFATE THERAPEUTICS ...Valamehr BahramChief Development O ...SellS117.602,756324,10384,45587.2 K to 84.5 K (-3.16 %)
Jan 12 2021FATEFATE THERAPEUTICS ...TAHL CINDYGeneral Counsel and ...SellS109.6587295,61890,03590.9 K to 90 K (-0.96 %)
Jan 12 2021FATEFATE THERAPEUTICS ...TAHL CINDYGeneral Counsel and ...SellS110.761,050116,29690,90792 K to 90.9 K (-1.14 %)
Jan 12 2021FATEFATE THERAPEUTICS ...TAHL CINDYGeneral Counsel and ...SellS111.621,332148,67391,95793.3 K to 92 K (-1.43 %)
Jan 12 2021FATEFATE THERAPEUTICS ...TAHL CINDYGeneral Counsel and ...SellS114.7615117,32893,28993.4 K to 93.3 K (-0.16 %)
Jan 12 2021FATEFATE THERAPEUTICS ...TAHL CINDYGeneral Counsel and ...SellS115.80872100,97793,44094.3 K to 93.4 K (-0.92 %)
Jan 12 2021FATEFATE THERAPEUTICS ...TAHL CINDYGeneral Counsel and ...SellS117.152,451287,14494,31296.8 K to 94.3 K (-2.53 %)
Jan 12 2021FATEFATE THERAPEUTICS ...TAHL CINDYGeneral Counsel and ...SellS117.602,755323,98596,76399.5 K to 96.8 K (-2.77 %)
Jan 12 2021FATEFATE THERAPEUTICS ...Shoemaker Daniel DChief Scientific Of ...SellS109.6587195,50983,60984.5 K to 83.6 K (-1.03 %)
Jan 12 2021FATEFATE THERAPEUTICS ...Shoemaker Daniel DChief Scientific Of ...SellS110.761,050116,29684,48085.5 K to 84.5 K (-1.23 %)
Jan 12 2021FATEFATE THERAPEUTICS ...Shoemaker Daniel DChief Scientific Of ...SellS111.621,332148,67385,53086.9 K to 85.5 K (-1.53 %)
Jan 12 2021FATEFATE THERAPEUTICS ...Shoemaker Daniel DChief Scientific Of ...SellS114.7615117,32886,86287 K to 86.9 K (-0.17 %)
Jan 12 2021FATEFATE THERAPEUTICS ...Shoemaker Daniel DChief Scientific Of ...SellS115.80872100,97787,01387.9 K to 87 K (-0.99 %)
Jan 12 2021FATEFATE THERAPEUTICS ...Shoemaker Daniel DChief Scientific Of ...SellS117.152,451287,14487,88590.3 K to 87.9 K (-2.71 %)
Jan 12 2021FATEFATE THERAPEUTICS ...Shoemaker Daniel DChief Scientific Of ...SellS117.602,755323,98590,33693.1 K to 90.3 K (-2.96 %)
Jan 12 2021FATEFATE THERAPEUTICS ...Redmile Group, LLCDirectorOption ExerciseP0.00257,310257257,310
Jan 12 2021FATEFATE THERAPEUTICS ...Redmile Group, LLCDirectorBuyP85.50327,48527,999,96812,957,22212.6 M to 13 M (+2.59 %)
Dec 18 2020FATEFATE THERAPEUTICS ...Wolchko J ScottPresident and CEOOption ExerciseM6.6220,000132,40054,846
Dec 18 2020FATEFATE THERAPEUTICS ...Wolchko J ScottPresident and CEOSellS93.441009,344419,969420.1 K to 420 K (-0.02 %)
Dec 18 2020FATEFATE THERAPEUTICS ...Wolchko J ScottPresident and CEOSellS92.942,796259,865420,069422.9 K to 420.1 K (-0.66 %)
Dec 18 2020FATEFATE THERAPEUTICS ...Wolchko J ScottPresident and CEOSellS91.7713,9361,278,914422,865436.8 K to 422.9 K (-3.19 %)
Dec 18 2020FATEFATE THERAPEUTICS ...Wolchko J ScottPresident and CEOSellS90.983,168288,229436,801440 K to 436.8 K (-0.72 %)
Dec 18 2020FATEFATE THERAPEUTICS ...Wolchko J ScottPresident and CEOBuyM6.6220,000132,400439,969420 K to 440 K (+4.76 %)
Dec 15 2020FATEFATE THERAPEUTICS ...Valamehr BahramChief Development O ...Option ExerciseM2.9025,00072,50041,156
Dec 15 2020FATEFATE THERAPEUTICS ...Valamehr BahramChief Development O ...SellS102.7510010,27587,21187.3 K to 87.2 K (-0.11 %)
Dec 15 2020FATEFATE THERAPEUTICS ...Valamehr BahramChief Development O ...SellS102.061,006102,67587,31188.3 K to 87.3 K (-1.14 %)
Dec 15 2020FATEFATE THERAPEUTICS ...Valamehr BahramChief Development O ...SellS100.9740040,38888,31788.7 K to 88.3 K (-0.45 %)
Dec 15 2020FATEFATE THERAPEUTICS ...Valamehr BahramChief Development O ...SellS99.773,822381,31588,71792.5 K to 88.7 K (-4.13 %)
Dec 15 2020FATEFATE THERAPEUTICS ...Valamehr BahramChief Development O ...SellS98.803,148311,01392,53995.7 K to 92.5 K (-3.29 %)
Dec 15 2020FATEFATE THERAPEUTICS ...Valamehr BahramChief Development O ...SellS97.702,946287,81295,68798.6 K to 95.7 K (-2.99 %)
Dec 15 2020FATEFATE THERAPEUTICS ...Valamehr BahramChief Development O ...SellS96.6511,7651,137,14198,633110.4 K to 98.6 K (-10.66 %)
Dec 15 2020FATEFATE THERAPEUTICS ...Valamehr BahramChief Development O ...SellS95.891,813173,857110,398112.2 K to 110.4 K (-1.62 %)
Dec 15 2020FATEFATE THERAPEUTICS ...Valamehr BahramChief Development O ...BuyM2.9025,00072,500112,21187.2 K to 112.2 K (+28.67 %)
Nov 16 2020FATEFATE THERAPEUTICS ...Shoemaker Daniel DChief Scientific Of ...SellS52.4014,781774,51493,091107.9 K to 93.1 K (-13.70 %)
Nov 16 2020FATEFATE THERAPEUTICS ...Shoemaker Daniel DChief Scientific Of ...SellS51.605,287272,825107,872113.2 K to 107.9 K (-4.67 %)
Nov 16 2020FATEFATE THERAPEUTICS ...Shoemaker Daniel DChief Scientific Of ...SellS50.374,932248,407113,159118.1 K to 113.2 K (-4.18 %)
Nov 16 2020FATEFATE THERAPEUTICS ...Wolchko J ScottPresident and CEOOption ExerciseM6.6210,15467,21974,846
Nov 16 2020FATEFATE THERAPEUTICS ...Wolchko J ScottPresident and CEOOption ExerciseM7.879,84677,4880
Nov 16 2020FATEFATE THERAPEUTICS ...Wolchko J ScottPresident and CEOOption ExerciseM2.7310,00027,300210,000
Nov 16 2020FATEFATE THERAPEUTICS ...Wolchko J ScottPresident and CEOOption ExerciseM2.7330,00081,900220,000
Nov 16 2020FATEFATE THERAPEUTICS ...Wolchko J ScottPresident and CEOSellS51.0310,154518,159419,969430.1 K to 420 K (-2.36 %)
Nov 16 2020FATEFATE THERAPEUTICS ...Wolchko J ScottPresident and CEOBuyM6.6210,15467,219430,123420 K to 430.1 K (+2.42 %)
Nov 16 2020FATEFATE THERAPEUTICS ...Wolchko J ScottPresident and CEOSellS51.039,846502,441419,969429.8 K to 420 K (-2.29 %)
Nov 16 2020FATEFATE THERAPEUTICS ...Wolchko J ScottPresident and CEOBuyM7.879,84677,488429,815420 K to 429.8 K (+2.34 %)
Nov 16 2020FATEFATE THERAPEUTICS ...Wolchko J ScottPresident and CEOSellS51.0310,000510,300419,969430 K to 420 K (-2.33 %)
Nov 16 2020FATEFATE THERAPEUTICS ...Wolchko J ScottPresident and CEOBuyM2.7310,00027,300429,969420 K to 430 K (+2.38 %)
Nov 16 2020FATEFATE THERAPEUTICS ...Wolchko J ScottPresident and CEOSellS54.471,864101,534419,969421.8 K to 420 K (-0.44 %)
Nov 16 2020FATEFATE THERAPEUTICS ...Wolchko J ScottPresident and CEOSellS53.9810,846585,505421,833432.7 K to 421.8 K (-2.51 %)
Nov 16 2020FATEFATE THERAPEUTICS ...Wolchko J ScottPresident and CEOSellS52.662,088109,961432,679434.8 K to 432.7 K (-0.48 %)
Nov 16 2020FATEFATE THERAPEUTICS ...Wolchko J ScottPresident and CEOSellS51.6115,202784,524434,767450 K to 434.8 K (-3.38 %)
Nov 16 2020FATEFATE THERAPEUTICS ...Wolchko J ScottPresident and CEOBuyM2.7330,00081,900449,969420 K to 450 K (+7.14 %)
Nov 06 2020FATEFATE THERAPEUTICS ...TAHL CINDYGeneral Counsel and ...Option ExerciseM2.9010,00029,00063,149
Nov 06 2020FATEFATE THERAPEUTICS ...TAHL CINDYGeneral Counsel and ...Option ExerciseM2.739,28225,34025,000
Nov 06 2020FATEFATE THERAPEUTICS ...TAHL CINDYGeneral Counsel and ...Option ExerciseM2.7351,519140,64734,282
Nov 06 2020FATEFATE THERAPEUTICS ...TAHL CINDYGeneral Counsel and ...SellS51.152,600132,99999,518102.1 K to 99.5 K (-2.55 %)
Nov 06 2020FATEFATE THERAPEUTICS ...TAHL CINDYGeneral Counsel and ...SellS50.5516,682843,253102,118118.8 K to 102.1 K (-14.04 %)
Nov 06 2020FATEFATE THERAPEUTICS ...TAHL CINDYGeneral Counsel and ...BuyM2.9010,00029,000118,800108.8 K to 118.8 K (+9.19 %)
Nov 06 2020FATEFATE THERAPEUTICS ...TAHL CINDYGeneral Counsel and ...BuyM2.739,28225,340108,80099.5 K to 108.8 K (+9.33 %)
Nov 06 2020FATEFATE THERAPEUTICS ...TAHL CINDYGeneral Counsel and ...SellS50.4151,5192,597,14099,518151 K to 99.5 K (-34.11 %)
Nov 06 2020FATEFATE THERAPEUTICS ...TAHL CINDYGeneral Counsel and ...BuyM2.7351,519140,647151,03799.5 K to 151 K (+51.77 %)
Oct 20 2020FATEFATE THERAPEUTICS ...TAHL CINDYGeneral Counsel and ...Option ExerciseM2.7329,19979,71385,801
Oct 20 2020FATEFATE THERAPEUTICS ...TAHL CINDYGeneral Counsel and ...SellS50.2529,1991,467,21299,518128.7 K to 99.5 K (-22.68 %)
Oct 20 2020FATEFATE THERAPEUTICS ...TAHL CINDYGeneral Counsel and ...BuyM2.7329,19979,713128,71799.5 K to 128.7 K (+29.34 %)
Oct 02 2020FATEFATE THERAPEUTICS ...TAHL CINDYGeneral Counsel and ...Option ExerciseM2.7335,00095,550115,000
Oct 02 2020FATEFATE THERAPEUTICS ...TAHL CINDYGeneral Counsel and ...SellS41.956,983292,92999,518106.5 K to 99.5 K (-6.56 %)
Oct 02 2020FATEFATE THERAPEUTICS ...TAHL CINDYGeneral Counsel and ...SellS41.096,260257,234106,501112.8 K to 106.5 K (-5.55 %)
Oct 02 2020FATEFATE THERAPEUTICS ...TAHL CINDYGeneral Counsel and ...SellS40.2621,757875,902112,761134.5 K to 112.8 K (-16.17 %)
Oct 02 2020FATEFATE THERAPEUTICS ...TAHL CINDYGeneral Counsel and ...BuyM2.7335,00095,550134,51899.5 K to 134.5 K (+35.17 %)
Sep 16 2020FATEFATE THERAPEUTICS ...Valamehr BahramChief Development O ...Option ExerciseM2.9021,92463,58066,156
Sep 16 2020FATEFATE THERAPEUTICS ...Valamehr BahramChief Development O ...Option ExerciseM1.693,0765,1980
Sep 16 2020FATEFATE THERAPEUTICS ...Valamehr BahramChief Development O ...SellS37.4960022,49487,21187.8 K to 87.2 K (-0.68 %)
Sep 16 2020FATEFATE THERAPEUTICS ...Valamehr BahramChief Development O ...SellS36.937,016259,08587,81194.8 K to 87.8 K (-7.40 %)
Sep 16 2020FATEFATE THERAPEUTICS ...Valamehr BahramChief Development O ...SellS36.0316,784604,65494,827111.6 K to 94.8 K (-15.04 %)
Sep 16 2020FATEFATE THERAPEUTICS ...Valamehr BahramChief Development O ...SellS34.6560020,792111,611112.2 K to 111.6 K (-0.53 %)
Sep 16 2020FATEFATE THERAPEUTICS ...Valamehr BahramChief Development O ...BuyM2.9021,92463,580112,21190.3 K to 112.2 K (+24.28 %)
Sep 16 2020FATEFATE THERAPEUTICS ...Valamehr BahramChief Development O ...BuyM1.693,0765,19890,28787.2 K to 90.3 K (+3.53 %)
Sep 16 2020FATEFATE THERAPEUTICS ...Shoemaker Daniel DChief Scientific Of ...SellS37.125,713212,074118,091123.8 K to 118.1 K (-4.61 %)
Sep 16 2020FATEFATE THERAPEUTICS ...Shoemaker Daniel DChief Scientific Of ...SellS36.1117,887645,909123,804141.7 K to 123.8 K (-12.62 %)
Sep 16 2020FATEFATE THERAPEUTICS ...Shoemaker Daniel DChief Scientific Of ...SellS35.401,40049,557141,691143.1 K to 141.7 K (-0.98 %)
Aug 19 2020FATEFATE THERAPEUTICS ...Dulac Edward J IIIChief Financial Off ...Option ExerciseA35.52160,0005,683,200160,000
Aug 19 2020FATEFATE THERAPEUTICS ...Dulac Edward J IIIChief Financial Off ...GrantA0.0040,000040,0000 to 40 K
Jun 17 2020FATEFATE THERAPEUTICS ...Redmile Group, LLCDirectorBuyP28.311,412,92839,999,99212,629,73711.2 M to 12.6 M (+12.60 %)
May 05 2020FATEFATE THERAPEUTICS ...Redmile Group, LLCDirectorOption ExerciseA26.5916,000425,44016,000
May 05 2020FATEFATE THERAPEUTICS ...Lee Michael StewartDirectorOption ExerciseA26.5916,000425,44016,000

Page:   1 2 3 4 4 next >

Contact us | Follow us on Twitter